Sorafenib: activity and clinical application in patients with hepatocellular carcinoma

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.12, Iss.2, 2011-02, pp. : 303-313

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Application of Sorafenib for Treating Hepatocellular Carcinoma and Beyond

Clinical Cancer Drugs, Vol. 2, Iss. 2, 2015-10 ,pp. : 128-137

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Application of Sorafenib for Treating Hepatocellular Carcinoma and Beyond

Clinical Cancer Drugs, Vol. 2, Iss. 2, 2015-11 ,pp. : 128-137

Bentham Science Publishers

Access to resources Recommend Favorite

Sorafenib (BAY 43-9006) in Hepatocellular Carcinoma Patients: From Discovery to Clinical Development

Current Medicinal Chemistry, Vol. 19, Iss. 7, 2012-03 ,pp. : 938-944

Bentham Science Publishers

Access to resources Recommend Favorite

Selection of Patients with Hepatocellular Carcinoma for Sorafenib

By Abou-Alfa Ghassan K.

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 7, Iss. 4, 2009-04 ,pp. : 397-403

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Sorafenib: In Hepatocellular Carcinoma

By Simpson Dene Keating Gillian M.

Drugs, Vol. 68, Iss. 2, 2008-01 ,pp. : 251-258

Adis International

Access to resources Recommend Favorite